These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 599082)

  • 1. Chemical studies on tuberactinomycin. XV. Total synthesis of tuberactinomycin O.
    Teshima T; Nomoto S; Wakamiya T; Shiba T
    J Antibiot (Tokyo); 1977 Dec; 30(12):1073-9. PubMed ID: 599082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical studies on tuberactinomycin. VIII. Isolation of tuberactinamine N, the cyclic peptide moiety of tuberactinomycin N, and conversion of tuberactinomycin N to O.
    Wakamiya T; Shiba T
    J Antibiot (Tokyo); 1975 Apr; 28(4):292-7. PubMed ID: 808523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical studies on tuberactinomycin. XIII. Modification of beta-ureidodehydroalanine residue in tuberactinomycin N.
    Nomoto S; Shiba T
    J Antibiot (Tokyo); 1977 Nov; 30(11):1008-11. PubMed ID: 591454
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemical studies on tuberactinomycin. XVI. Synthesis of tuberactinomycin N.
    Shiba T; Ando T; Teshima T
    J Antibiot (Tokyo); 1979 Oct; 32(10):1078-9. PubMed ID: 528372
    [No Abstract]   [Full Text] [Related]  

  • 5. Preparation of radioisotopically labeled tuberactinomycin, [beta-[14C]ureido-dehydroalanine5]-tuberactinomycin o.
    Nomoto S; Teshima T; Shiba T
    J Antibiot (Tokyo); 1978 Aug; 31(8):792-3. PubMed ID: 690011
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experimental studies in vitro on the antituberculous activities of tuberactinomycin (TUM) and tuberactinomycin-N (TUM-N) (author's transl)].
    Maekawa N; Ikeda N; Oda Y; Uratsuji Y; Inagake H
    Kekkaku; 1977 May; 52(5):211-8. PubMed ID: 407391
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on tuberactinomycin. II. Isolation and properties of tuberactinomycin-N, a new tuberactinomycin group antibiotic.
    Ando T; Matsuura K; Izumi R; Noda T; Take T
    J Antibiot (Tokyo); 1971 Oct; 24(10):680-6. PubMed ID: 5158584
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on tuberactinomycin (tuberactin), a new antibiotic. I. Taxonomy of producing strain, isolation and characterization.
    Nagata A; Ando T; Izumi R; Sakakibara H; Take T
    J Antibiot (Tokyo); 1968 Dec; 21(12):681-7. PubMed ID: 5752384
    [No Abstract]   [Full Text] [Related]  

  • 9. Cross-resistant relationships among the aminoglucoside antibiotics in Mycobacterium tuberculosis.
    Tsukamura M; Mizuno S
    J Gen Microbiol; 1975 Jun; 88(2):269-74. PubMed ID: 50402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Basic studies on viomycin and tuberactinomycin (author's transl)].
    Aoyagi T; Kawai T; Yamada Y; Fujino T; Kaneko K
    Kekkaku; 1975 Oct; 50(10):295-301. PubMed ID: 175205
    [No Abstract]   [Full Text] [Related]  

  • 11. A study on ester thiosemicarbazones.
    Ikizler AA; Kahveci B; Johansson CB; Celik C; Yüksek H
    Acta Pol Pharm; 1997; 54(4):307-12. PubMed ID: 9511459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical studies on tuberactinomycin. VI. The absolute configuration of gamma-hydroxy-beta-lysine in tuberactinomycins A and N.
    Wakamiya T; Shiba T
    J Antibiot (Tokyo); 1974 Nov; 27(11):900-2. PubMed ID: 4452664
    [No Abstract]   [Full Text] [Related]  

  • 13. Localization of co-resistance to streptomycin, kanamycin, capreomycin, and tuberactinomycin in core particles derived from ribosomes of viomycin-resistant Mycobacterium smegmatis.
    Yamada T; Mizuguchi Y; Suga K
    J Antibiot (Tokyo); 1976 Oct; 29(10):1124-6. PubMed ID: 62857
    [No Abstract]   [Full Text] [Related]  

  • 14. Experimental and clinical study on the antituberculous activity of tuberactinomycin-N, a new antibiotic.
    Toyoara M
    Bull Int Union Tuberc; 1974 Aug; 49 suppl 1():288-91. PubMed ID: 4468026
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemical studies on tuberactinomycin. 3. The chemical structure of viomycin (tuberactinomycin B).
    Noda T; Take T; Nagata A; Wakamiya T; Shiba T
    J Antibiot (Tokyo); 1972 Jul; 25(7):427-8. PubMed ID: 4350196
    [No Abstract]   [Full Text] [Related]  

  • 16. [Critical concentrations for resistances of tubercle bacilli to tuberactinomycin-N, viomycin, capreomycin, and lividomycin in patients treated with these agents (cross-resistance-relationships among resistances to aminoglucoside-antibiotics found during chemotherapy for tuberculosis) (author's transl)].
    Tsukamura M; Mizuno S; Murata H; Oshima T
    Kekkaku; 1975 May; 50(4-5):123-30. PubMed ID: 49449
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical study on tuberactinomycin-N (TUM-N) and viomycin (VM) in retreatment of pulmonary tuberculosis (author's transl)].
    Kekkaku; 1974 Jul; 49(7):207-15. PubMed ID: 4372439
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthesis and biological activity of 5'-aminobenzoxazinorifamycin derivatives.
    Yamane T; Hashizume T; Yamashita K; Hosoe K; Hidaka T; Watanabe K; Kawaharada H; Kudoh S
    Chem Pharm Bull (Tokyo); 1992 Oct; 40(10):2707-11. PubMed ID: 1464100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of [14C]tuberactinomycin O, an antibiotic closely related to viomycin, to the bacterial ribosome.
    Misumi M; Tanaka N; Shiba T
    Biochem Biophys Res Commun; 1978 Jun; 82(3):971-6. PubMed ID: 212033
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification of the biosynthetic gene cluster and an additional gene for resistance to the antituberculosis drug capreomycin.
    Felnagle EA; Rondon MR; Berti AD; Crosby HA; Thomas MG
    Appl Environ Microbiol; 2007 Jul; 73(13):4162-70. PubMed ID: 17496129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.